NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-084-2007-0-US-05 The Use Of Histone Deacetylase (HDAC) Inhibitors For The Prevention And Cure Of Breast Cancer Brain Metastasis US National Stage 12/528,597 Abandoned
NIAID E-123-2007-0-US-04 Chimpaneze Monoclonal Antibodies That Neutralize Lethal And Edema Factors Of Anthrax Toxin US National Stage 12/528,427 8071100 Abandoned PDF
NIAID E-312-2008-0-PCT-02 Methods of Enriching and Using T-Regulatory Cells PCT PCT PCT/US2009/054631 Expired
NCI E-106-2006-3-EP-06 T Cell Receptors And Related Matrerials And Methods Of Use EP National Stage 09791694.4 Abandoned
NCI E-106-2006-3-GB-14 T Cell Receptors And Related Matrerials And Methods Of Use GB EP 09791694.4 Abandoned
NCI E-106-2006-3-FR-13 T Cell Receptors And Related Matrerials And Methods Of Use FR EP 09791694.4 Abandoned
NCI E-106-2006-3-DE-12 T Cell Receptors And Related Matrerials And Methods Of Use DE EP 09791694.4 Abandoned
NIDCR E-302-2008-0-FR-07 Chemopreventive of Head And Neck Squamous Cell Carcinoma FR EP 09791732.2 Issued
NIDCR E-302-2008-0-DE-06 Chemopreventive of Head And Neck Squamous Cell Carcinoma DE EP 09791732.2 Issued
NIDCR E-302-2008-0-GB-08 Chemopreventive of Head And Neck Squamous Cell Carcinoma GB EP 09791732.2 Issued
NIDCR E-302-2008-0-EP-04 Chemopreventive of Head And Neck Squamous Cell Carcinoma EP National Stage 09791732.2 Issued
NCI E-106-2006-3-EP-08 T Cell Receptors And Related Materials And Methods Of Use EP DIV 13185475.4 Abandoned
NCI E-106-2006-3-AU-04 T-cell Receptors and Related Materials And Methods Of Use AU National Stage 2009282886 Abandoned
NCI E-323-2003-0-US-04 Minimally Immunogenic Variants Of SDR-Grafted Humanized Antibody CC49 And Their Use US DIV 12/544,978 7915396 Abandoned PDF
NIDCR E-160-2000-1-US-05 Nucleic Acids Encoding T2R TASTE RECEPTORS US DIV 12/544,854 7868150 Expired PDF
NIDCR E-302-2008-0-PCT-02 Chemopreventive of Head And Neck Squamous Cell Carcinoma PCT PCT PCT/US2009/054478 Expired
NCI E-106-2006-3-PCT-02 T-cell Receptors Recognizing TNF-related Apoptosis Inducing Ligand (TRAIL) And Death Receptor 4 (Dr4) Complex Particularly As Presented By Human Tumors PCT PCT PCT/US2009/54384 Expired
NCI E-106-2006-3-CA-05 T-cell Receptors and Related Materials and Methods of Use CA National Stage 2734838 Abandoned
NCI E-287-2003-4-US-01 Derivatives of APF and Methods of Use US CIP 12/543,455 9079936 Abandoned PDF
NCI E-287-2009-3-PCT-01 Antiproliferative Factors And Methods Of Use PCT PCT COMB PCT/US2009/054207 Expired
NCI E-287-2009-3-EP-05 Derivatives of APF and Methods of Use EP National Stage 09808738.0 Abandoned
NCI E-287-2009-3-CA-04 Derivatives of APF and Methods of Use CA National Stage 2734325 Abandoned
NCI E-287-2009-3-AU-02 Antiproliferative Factors And Methods Of Use AU National Stage 2009282625 Abandoned
NCI E-157-2007-0-US-03 Multifunctional Nanoparticles and Compositions and Methods of Use Thereof US National Stage 12/531,841 Abandoned
NIMH E-289-2009-0-US-01 Novel Fast-acting SNARE-cleaving Enzyme That Readily Penetrates Tissue. US 61/234,429 Abandoned
NEI E-169-2008-0-EP-05 Methods for USing Interferon Gamma to Absorb Fluid from the Subretinal Space EP National Stage 09791514.4 Issued
NEI E-169-2008-0-GB-10 Methods for USing Interferon Gamma to Absorb Fluid from the Subretinal Space GB EP 09791514.4 Issued
NEI E-169-2008-0-DE-08 Methods for USing Interferon Gamma to Absorb Fluid from the Subretinal Space DE EP 09791514.4 Issued
NEI E-169-2008-0-FR-09 Methods for USing Interferon Gamma to Absorb Fluid from the Subretinal Space FR EP 09791514.4 Issued
NEI E-169-2008-0-AU-03 Methods For Using Interferon Gamma To Absorb Fluid Form The Subretinal Space AU National Stage 2009281849 Issued
NEI E-169-2008-0-US-06 METHODS FOR USING INTERFERON GAMMA TO ABSORB FLUID FROM THE SUBRETINAL SPACE US National Stage 13/058,359 8697046 Issued PDF
NICHD E-304-2008-0-US-02 Vaccines Against Influenza Virus US ORD 12/541,804 8658180 Abandoned PDF
NCI E-095-2007-1-US-01 Pro-Angiogenic Genes In Ovarian Tumor Endothelial Cell Isolates US CIP 12/541,729 8440393 Abandoned PDF
NIDA E-251-2002-1-US-05 Structurally Rigid Dopamine D3 Receptor Selective Ligands And Process For Making Them US DIV 12/558,983 8119642 Abandoned PDF
NIAID E-303-2008-0-PCT-02 Insect Salivary Proteins, Particularly Sand Fly Salivary Proteins Work As Non-classical Natural Adjuvants Driving A Specific Immune Response That Accelerate The Immune Response To Another Protein Or Pathogen PCT PCT PCT/US2009/053941 Expired
NICHD E-308-2008-0-PCT-02 A New Vaccine For Shigella Sonnei That Is The Leading Cause Of Shigella In The U.S. And In Most Developed Countries World-wide PCT PCT PCT/US2009/053897 Expired
NEI E-169-2008-0-PCT-02 METHODS FOR USING INTERFERON GAMMA TO ABSORB FLUID FROM THE SUBRETINAL SPACE PCT PCT PCT/US2009/053808 Expired
NCI E-257-2009-0-US-01 Use Of IL-15 To Increase Thymic Output US 61/234,152 Abandoned
NCI E-259-2009-0-US-01 Use Of IL-15 Preparations To Treat Lymphopenia US 61/234,155 Abandoned
NCI E-154-2006-0-US-03 Gamma Satellite Insulator Sequences and Their Use in Preventing Gene Silencing US National Stage 12/527,122 9018011 Issued PDF
NCATS E-162-2008-0-PCT-02 Oxadiazole-2-Oxides As Antischistomsomal Agents PCT PCT PCT/US2009/53715 Abandoned
NCI E-319-2005-0-US-07 Triapine-induced Tumor Cell Radiosensitization US National Stage 11/992,002 Abandoned
NCATS E-162-2008-0-IN-05 Oxadiazole-2-Oxides As Antischistomsomal Agents IN National Stage 729/CHENP/2011 Abandoned
NCATS E-162-2008-0-EP-04 Oxadiazole-2-Oxides As Antischistomsomal Agents EP National Stage 09791490.7 Abandoned
NIA E-171-2008-0-US-01 Individualized Therapy Of Single Gene Disorders By Genetically Modified Adult Stem Cells US 61/233,537 Abandoned
NCATS E-162-2008-0-KR-06 Oxadiazole-2-Oxides As Antischistomsomal Agents KR National Stage 10-2011-7003316 Abandoned
NCATS E-162-2008-0-CA-03 Oxadiazole-2-Oxides As Antischistomsomal Agents CA National Stage 2733190 Abandoned
NCI E-256-1998-0-JP-30 Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof JP DIV 2009-187330 Expired
NINDS E-020-2007-0-US-03 Transmit Profile Control In MRI US National Stage 12/449,514 8125225 Issued PDF
NIMH E-305-2008-0-PCT-02 Rare SAPAP3 Missense Variants That Could Be An Important Genetic Risk Factor For Trichotillomania And Obsessive-compulsive Disorder PCT PCT PCT/US2009/053578 Expired